HGFAC

HGF activator

PDB rendering based on 1ybw.
Available structures
PDB Ortholog search: PDBe, RCSB
Identifiers
SymbolsHGFAC ; HGFA
External IDsOMIM: 604552 MGI: 1859281 HomoloGene: 1170 GeneCards: HGFAC Gene
EC number3.4.21.-
RNA expression pattern
More reference expression data
Orthologs
SpeciesHumanMouse
Entrez308354426
EnsemblENSG00000109758ENSMUSG00000029102
UniProtQ04756Q9R098
RefSeq (mRNA)NM_001297439NM_019447
RefSeq (protein)NP_001284368NP_062320
Location (UCSC)Chr 4:
3.44 – 3.45 Mb
Chr 5:
35.04 – 35.05 Mb
PubMed search

Hepatocyte growth factor activator is a protein that in humans is encoded by the HGFAC gene.[1][2][3]

The protein encoded by this gene belongs to peptidase family S1. It is first synthesized as an inactive single-chain precursor before being activated to a heterodimeric form by endoproteolytic processing. It acts as serine protease that converts hepatocyte growth factor to the active form.[3]

References

  1. Miyazawa K, Shimomura T, Kitamura A, Kondo J, Morimoto Y, Kitamura N (Jun 1993). "Molecular Cloning and Sequence Analysis of the cDNA for a Human Serine Protease Responsible for Activation of Hepatocyte Growth Factor. Structural similarity of the protease precursor to blood coagulation factor XII". J Biol Chem 268 (14): 10024–8. PMID 7683665.
  2. Shimomura T, Kondo J, Ochiai M, Naka D, Miyazawa K, Morimoto Y, Kitamura N (Dec 1993). "Activation of the zymogen of hepatocyte growth factor activator by thrombin". J Biol Chem 268 (30): 22927–32. PMID 8226803.
  3. 3.0 3.1 "Entrez Gene: HGFAC HGF activator".

Further reading

  • Nakamura T (1992). "Structure and function of hepatocyte growth factor.". Prog. Growth Factor Res. 3 (1): 67–85. doi:10.1016/0955-2235(91)90014-U. PMID 1838014.
  • Shimomura T, Ochiai M, Kondo J, Morimoto Y (1992). "A novel protease obtained from FBS-containing culture supernatant, that processes single chain form hepatocyte growth factor to two chain form in serum-free culture.". Cytotechnology 8 (3): 219–29. doi:10.1007/BF02522039. PMID 1368819.
  • Miyazawa K, Shimomura T, Kitamura N (1996). "Activation of hepatocyte growth factor in the injured tissues is mediated by hepatocyte growth factor activator.". J. Biol. Chem. 271 (7): 3615–8. doi:10.1074/jbc.271.7.3615. PMID 8631970.
  • Shimomura T, Denda K, Kitamura A et al. (1997). "Hepatocyte growth factor activator inhibitor, a novel Kunitz-type serine protease inhibitor.". J. Biol. Chem. 272 (10): 6370–6. doi:10.1074/jbc.272.10.6370. PMID 9045658.
  • Kawaguchi T, Qin L, Shimomura T et al. (1997). "Purification and cloning of hepatocyte growth factor activator inhibitor type 2, a Kunitz-type serine protease inhibitor.". J. Biol. Chem. 272 (44): 27558–64. doi:10.1074/jbc.272.44.27558. PMID 9346890.
  • Miyazawa K, Wang Y, Minoshima S et al. (1999). "Structural organization and chromosomal localization of the human hepatocyte growth factor activator gene--phylogenetic and functional relationship with blood coagulation factor XII, urokinase, and tissue-type plasminogen activator.". Eur. J. Biochem. 258 (2): 355–61. doi:10.1046/j.1432-1327.1998.2580355.x. PMID 9874200.
  • Kataoka H, Shimomura T, Kawaguchi T et al. (2001). "Hepatocyte growth factor activator inhibitor type 1 is a specific cell surface binding protein of hepatocyte growth factor activator (HGFA) and regulates HGFA activity in the pericellular microenvironment.". J. Biol. Chem. 275 (51): 40453–62. doi:10.1074/jbc.M006412200. PMID 11013244.
  • Kataoka H, Meng JY, Itoh H et al. (2001). "Localization of hepatocyte growth factor activator inhibitor type 1 in Langhans' cells of human placenta.". Histochem. Cell Biol. 114 (6): 469–75. PMID 11201608.
  • Strausberg RL, Feingold EA, Grouse LH et al. (2003). "Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences.". Proc. Natl. Acad. Sci. U.S.A. 99 (26): 16899–903. doi:10.1073/pnas.242603899. PMC 139241. PMID 12477932.
  • Anderson NL, Polanski M, Pieper R et al. (2004). "The human plasma proteome: a nonredundant list developed by combination of four separate sources.". Mol. Cell Proteomics 3 (4): 311–26. doi:10.1074/mcp.M300127-MCP200. PMID 14718574.
  • Tjin EP, Derksen PW, Kataoka H et al. (2004). "Multiple myeloma cells catalyze hepatocyte growth factor (HGF) activation by secreting the serine protease HGF-activator.". Blood 104 (7): 2172–5. doi:10.1182/blood-2003-12-4386. PMID 15172968.
  • Zhang Z, Henzel WJ (2005). "Signal peptide prediction based on analysis of experimentally verified cleavage sites.". Protein Sci. 13 (10): 2819–24. doi:10.1110/ps.04682504. PMC 2286551. PMID 15340161.
  • Shia S, Stamos J, Kirchhofer D et al. (2005). "Conformational lability in serine protease active sites: structures of hepatocyte growth factor activator (HGFA) alone and with the inhibitory domain from HGFA inhibitor-1B.". J. Mol. Biol. 346 (5): 1335–49. doi:10.1016/j.jmb.2004.12.048. PMID 15713485.
  • Tjin EP, Groen RW, Vogelzang I et al. (2006). "Functional analysis of HGF/MET signaling and aberrant HGF-activator expression in diffuse large B-cell lymphoma.". Blood 107 (2): 760–8. doi:10.1182/blood-2005-05-1929. PMID 16189274.
  • Liu T, Qian WJ, Gritsenko MA et al. (2006). "Human plasma N-glycoproteome analysis by immunoaffinity subtraction, hydrazide chemistry, and mass spectrometry.". J. Proteome Res. 4 (6): 2070–80. doi:10.1021/pr0502065. PMC 1850943. PMID 16335952.